Chronic GVHD and Concurrent New-Onset Nephrotic Syndrome in Allogeneic Transplant Recipients. Incidence, Pattern and Therapeutic Outcomes

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2014.261
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Palifermin Reduces Incidence and Severity of Oral Mucositis in Allogeneic Stem-Cell Transplant Recipients

Bone Marrow Transplantation
TransplantationHematology
2008English

Incidence and Risk Factors for Metabolic Syndrome in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients-A Tertiary Care Center Experience

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Late Graft Failure in Heart Transplant Recipients: Incidence, Risk Factors and Clinical Outcomes

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

Treatment of Chronic Hepatitis C Virus in Allogeneic Bone Marrow Transplant Recipients

Bone Marrow Transplantation
TransplantationHematology
2005English

Incidence and Outcomes of Primary Central Nervous System Lymphoma in Solid Organ Transplant Recipients

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2017English

Outcomes After Allogeneic Transplant in Patients With Wiskott-Aldrich Syndrome.

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

New-Onset Diabetes After Transplant: Incidence, Risk Factors and Outcome

South African Medical Journal
Medicine
2017English

Donor Race and Outcomes in Kidney Transplant Recipients

Clinical Transplantation
Transplantation
2012English

Concurrent Validity of Kidney Transplant Questionnaire in US Renal Transplant Recipients

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy